Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Fibrodysplasia Ossificans Progressiva”

Showing 4 of 0 results

Testing effectiveness (Phase 2)Study completedNCT02279095
What this trial is testing

An Open-Label Extension Study of Palovarotene Treatment in Fibrodysplasia Ossificans Progressiva (FOP)

Who this might be right for
Fibrodysplasia Ossificans Progressiva
Clementia Pharmaceuticals Inc. 58
Testing effectiveness (Phase 2)Ended earlyNCT02521792
What this trial is testing

In-Home Evaluation of Episodic Administration of Palovarotene in Fibrodysplasia Ossificans Progressiva (FOP) Subjects

Who this might be right for
Fibrodysplasia Ossificans Progressiva
Clementia Pharmaceuticals Inc. 6
Large-scale testing (Phase 3)Not Yet RecruitingNCT07559513
What this trial is testing

Investigate the Safety, Pharmacokinetics (PK), and Efficacy of Garetosmab in Children and Adolescents With Fibrodysplasia Ossificans Progressiva (FOP)

Who this might be right for
Fibrodysplasia Ossificans Progressiva (FOP)
Regeneron Pharmaceuticals 18
Not applicableLooking for participantsNCT02745158
What this trial is testing

The Fibrodysplasia Ossificans Progressiva (FOP) Registry

Who this might be right for
Fibrodysplasia Ossificans Progressiva (FOP)
The International FOP Association 800

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation